Allarity Therapeutics Inc (ALLR)

06:08 AM

Is Allarity Therapeutics Inc. a good long term investmentBreakthrough financial growth - PrintWeekIndia

06:08 AM

05:04 AM

What drives Allarity Therapeutics Inc. stock priceLightning-fast growth - PrintWeekIndia

05:04 AM

Jul 24, 2025

Allarity Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional

Jul 24, 2025

Jul 22, 2025

How Allarity Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 22, 2025

Jul 20, 2025

What analysts say about Allarity Therapeutics Inc. stockTremendous return rates - Autocar Professional

Jul 20, 2025

Jul 18, 2025

Will Allarity Therapeutics Inc. stock benefit from interest rate changesFree Stock Investment Growth Plan - beatles.ru

Jul 18, 2025

Jul 18, 2025

Does Allarity Therapeutics Inc. stock pay reliable dividendsRisk Adjusted Stock Signals - Newser

Jul 18, 2025

Jul 16, 2025

Allarity Therapeutics Secures New EU Commercial Agreement - TipRanks

Jul 16, 2025

Jul 16, 2025

Why Allarity Therapeutics Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser

Jul 16, 2025

Jul 15, 2025

What makes Allarity Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 15, 2025

Jul 15, 2025

Allarity Therapeutics Announces New Licensing and - GlobeNewswire

Jul 15, 2025

Jul 15, 2025

Allarity Therapeutics Signs New Precision Oncology Licensing Deal for Breast Cancer | ALLR Stock News - Stock Titan

Jul 15, 2025

Jul 13, 2025

Allarity Therapeutics appoints Jeff Ervin as CFO - MSN

Jul 13, 2025

Jul 08, 2025

Jeffrey S. Ervin Appointed as Allarity’s New CFO - The Globe and Mail

Jul 08, 2025

Jul 07, 2025

Allarity Therapeutics appoints Jeff Ervin as new CFO By Investing.com - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

Allarity Therapeutics, Inc. Announces Chief Financial Officer Changes - MarketScreener

Jul 07, 2025

Jul 07, 2025

Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria

Jul 07, 2025

Jul 07, 2025

Allarity Therapeutics appoints Jeff Ervin as new CFO - Investing.com

Jul 07, 2025

Jul 07, 2025

Allarity Therapeutics Appoints Jeff Ervin To Succeed Alexander Epshinsky As CFO - Nasdaq

Jul 07, 2025

Jul 07, 2025

Allarity Therapeutics Appoints Jeff Ervin as New Chief Financial Officer - Nasdaq

Jul 07, 2025

Jul 07, 2025

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - GlobeNewswire

Jul 07, 2025

Jul 07, 2025

Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan

Jul 07, 2025

Jul 02, 2025

Allarity Therapeutics Secures Australian Patent for DRP® Platform - The Globe and Mail

Jul 02, 2025

Jun 30, 2025

Allarity Therapeutics Advances Phase 2 Stenoparib Trial - TipRanks

Jun 30, 2025

Jun 30, 2025

Allarity Therapeutics receives patent acceptance in Australia for cancer diagnostic - Investing.com

Jun 30, 2025

Jun 30, 2025

Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic - The Manila Times

Jun 30, 2025

Jun 27, 2025

Allarity Therapeutics Doses Second Patient in Phase 2 Ovarian Cancer Trial - MarketScreener

Jun 27, 2025